Insights and Analysis from the 2022 encapsia Industry Data Survey
As with all modern trials, ensuring that disparate data can be easily integrated and available on-demand to users for review analysis is key for fast decision making and critical for the clinical programs. Beyond regulatory compliance, the safety of patients is foremost on researcher’s minds. Sponsors are now trying to achieve a digital transformation in order to execute decentralized trials but realizing that old tools that are not up to the task keeps data siloed, adding time and risk as clinical teams jump between systems, hunting down needed information or relying on vendors to deliver reports that can lag a month behind the study.
Today’s trial complexity means more intensive data capture, and continuous flows are essential. Vital strategic decisions need to be made using real-time data analysis and intelligence from all sources.
In this webinar the panel will discuss:
- The impact of waiting for and aggregating reports
o Time
o Costs
o Risks
- Key barriers to getting needed trial data
- The importance of a holistic clinical data strategy for small and mid-sized biotech and pharmaceutical sponsors
o Defining organizational and clinical program requirements
o Partner selection: best of breed, platform, hybrid
- New data technologies to consider like eSource for DCT/hybrid, data science tools, data repositories
The goal of this webinar is to discuss these realities, various strategies, and today’s tech tools in order to remove the pain around remotely collecting and integrating disparate data and give you the insights you need, down to the source level, to take action and optimize your trials.
Presented by
Temitope A Keyes,
Executive Director, Technology - encapsia
Temitope (Tope) Keyes brings 23 years of clinical R&D experience, which began on the sponsor side, with the majority of that primarily in the eClinical solutions space. She has a passion for technology and its ability to advance vital clinical research and successful trial execution. Her experience includes pre-clinical purchasing and clinical outsourcing roles at Astrazeneca and Sanofi, followed by almost 15 years in business development with the likes of ERT, Synteract, Datatrak, and Axiom Real-Time Metrics. Tope joined Cmed Technology in 2020 where she drives the sales and marketing for the encapsia clinical technology platform.
Hope Meely,
Chief Clinical Officer - Slope
